Example: Heart Attack

Clinical Trials on Borderline Resectable Adenocarcinoma of the Head of the Pancrease

Total 9779 results

NCT05974839

Completed

Effect of Ocrelizumab on Cortical Lesion Accumulation in Patients With PPMS (ORATORIO-Cortical) (ORATORIO-Cort)

Primary Progressive Multiple Sclerosis
NCT01776060

Completed

Serial Collection of Primary Progressive Multiple Sclerosis Participants in the MURDOCK Study

Primary Progressive Multiple Sclerosis
NCT03846219

Active, not recruiting

MRI Trial to exPlore the efficAcy and Safety of IMU-838 in Relapsing Remitting Multiple Sclerosis (EMPhASIS) (EMPhASIS)

Relapsing-Remitting Multiple Sclerosis (RRMS)
NCT01194570

Completed

A Study of Ocrelizumab in Participants With Primary Progressive Multiple Sclerosis

Multiple Sclerosis, Primary Progressive
NCT05671055

Completed

CogMS - A Real-world Study Into Cognitive Impairment in People With Multiple Sclerosis

Multiple Sclerosis
NCT02971683

Completed

Trial to Evaluate the Efficacy and Safety of Abatacept in Combination With Standard Therapy Compared to Standard Therapy Alone in Improving Disease Activity in Adults With Active Idiopathic Inflammatory Myopathy

Dermatomyositis | Polymyositis | Autoimmune Necrotizing Myopathy | Overlap Myositis | Juvenile Myositis Above the Age of 18
NCT04486209

Completed

Non-invasive Spinal Cord Stimulation for Spasticity Control and Augmentation of Voluntary Motor Control in Individuals With Multiple Sclerosis (noSpasMS)

Multiple Sclerosis
NCT05438147

Completed

Effects of a CT-100 DiNaMo Component on Cognitive Functioning and Mood Symptoms

Multiple Sclerosis | Cancer | Mild Cognitive Impairment
NCT04795622

Completed

Evaluation of the Effectiveness and Safety of the Ulthera® DeepSEE® System for Treating Skin Laxity in the Lower Face and Submentum

Improvement in Skin Laxity of the Lower Face and Submentum
NCT04465084

Completed

Assessment of Language Disorders in Multiple Sclerosis Patients (LANSEP)

Sclerosis | Language Disorders
NCT04338646

Completed

Is the Severity of Urinary Disorders Related to Falls in People With Multiple Sclerosis

Multiple Sclerosis | Lower Urinary Tract Symptoms | Fall
NCT05218317

Completed

Evaluation of Relapse Presence in Multiple Sclerosis

Multiple Sclerosis, Relapsing-Remitting | Multiple Sclerosis Relapse
NCT05155644

Completed

Safety of Therapeutic Step-down in Neuromyelitis Optica (NMO)

Neuromyelitis Optica
NCT04082468

Withdrawn

VALIDATE: Factor VIII Trending for MS Relapse

Multiple Sclerosis
NCT02740296

Completed

Depression and Immune Function in Multiple Sclerosis (MS) (DENIM)

Multiple Sclerosis | Depressive Disorder, Major
NCT01536392

Completed

Oral Ondansetron Versus Transdermal Granisetron (Sancuso) for Women With Cervical, Endometrial or Vaginal Cancer Receiving Pelvic Chemoradiation

Cancer of the Cervix
NCT02414490

Completed

IVIg Treatment-Related Fluctuations in CIDP Patients Using Daily Grip Strength Measurements (GRIPPER)

Chronic Inflammatory Demyelinating Polyneuropathy
NCT03905161

Completed

Rhythmic Auditory Stimulation and Walking Speed in the 6-minute Walk Test

Myasthenia Gravis
NCT03161938

Completed

High vs Low Dose Dexamethasone on Complications in the Immediate Postoperative Phase (DEX-GANZ)

Postoperative Complications | Hip Dysplasia
NCT04265092

Completed

Therapeutic Benefit of Incobotulinum Toxin A for Spasticity of the Triceps Surae in Patients With Multiple Sclerosis (GAITOX)

Multiple Sclerosis
NCT03066752

Completed

Cognitive Dysfunction in MS: Using Altered Brain Oscillation to Link Molecular Mechanisms With Clinical Outcomes

Pediatric Multiple Sclerosis
NCT02881567

Terminated

Efficacy and Safety of Daclizumab in Participants With RRMS Switching From Natalizumab (SUSTAIN)

Relapsing-Remitting Multiple Sclerosis (RRMS)
NCT03605238

Withdrawn

Treatment of Relapsed and/or Refractory AQP4-IgG Seropositive NMOSD by Tandem CAR T Cells Targeting CD19 and CD20

Neuromyelitis Optica Spectrum Disorder
NCT04030637

Unknown

The Diagnostic Accuracy of Using Faecal-DNA Test (COLOSAFE) for Colorectal Cancer Screening

To Evaluate the Sensitivity and Specificity of a Test Kit in Hong Kong
NCT01892345

Terminated

A Randomized Controlled Trial of Eculizumab in AQP4 Antibody-positive Participants With NMO (PREVENT Study)

Neuromyelitis Optica | Neuromyelitis Optica Spectrum Disorder
NCT01379833

Completed

Prevalence of Decreased Corneal Sensation in Patients With Chronic Inflammatory Demyelinating Polyneuropathy

Chronic Inflammatory Demyelinating Polyneuropathy
NCT02726672

Terminated

Fatigue and Inspiratory Muscles Training in Patients With Multiple Sclerosis (AIRSEP)

Multiple Sclerosis
NCT03552211

Unknown

Evaluation of the Incidence of Relapses in Patients With Biotin-treated Progressive Multiple Sclerosis (IPBio-SeP)

Progressive Multiple Sclerosis
NCT01276145

Completed

Prevalence Of Internal Pudendal Artery Disease In Patients With Erectile Dysfunction Undergoing Diagnostic Coronary Angiography

To Assess the Presence of Internal Pudendal Artery Disease in Patients With Erectile Dysfunction Undergoing Coronary Angiography
NCT02170779

Completed

Developing and Testing a Comprehensive MS Spasticity Management Program

Multiple Sclerosis | Spasticity
NCT00871780

Completed

A Prospective, Open-label, Non-randomized, Clinical Trial to Determine if Natalizumab (Tysabri®) Improves Ambulatory Measures in Relapsing-remitting Multiple Sclerosis (RRMS) Patients (TIMER)

Relapsing Remitting Multiple Sclerosis (RRMS)
NCT01244139

Completed

Safety Study of BIIB033 in Subjects With Multiple Sclerosis

Multiple Sclerosis | Relapsing-Remitting Multiple Sclerosis
NCT02016222

Completed

Tear Analysis in the Diagnosis of Multiple Sclerosis (LARMES)

Primary Progressive Multiple Sclerosis
NCT01490840

Terminated

Effect of Physical ACtivity in Fingolimod Treated patiEnts (PACE) With Relapsing-remitting Multiple Sclerosis (PACE)

Fatigue in Multiple Sclerosis
NCT01927692

Completed

Therapeutic Plasma Exchange in MG (TPE)

Myasthenia Gravis
NCT00126737

Completed

Home-Based Exercise and Weight Control Program for Pain Control in Overweight Elderly With Osteoarthritis of the Knee

Pain | Obesity | Osteoarthritis | Chronic Diseases
NCT00168714

Completed

Pregnancy Exposure Registry for Avonex (Interferon Beta-1a)

Multiple Sclerosis | Pregnancy | Prenatal Exposure Delayed Effects
NCT01845896

Completed

Influence of High Intensity Exercise on Insulin Resistance, Muscle Contractile Properties, Aerobic Capacity and Body Composition in Multiple Sclerosis

Multiple Sclerosis | Healthy Controls
NCT01538225

Completed

Neurophysiological Study of Sativex in Multiple Sclerosis (MS) Spasticity (NS-MSS)

Multiple Sclerosis
NCT01939652

Completed

Restrictive Versus Standard Fluid Regime in Elective Minilaparotomy Abdominal Aortic Aneurysm Repair

Abdominal Aortic Aneurysm > 5.5 cm Effect of a Restricted Intravenous Fluid Regime on Complications and Hospital Stay After the Minilaparotomy AAA Repair.
NCT00428584

Completed

RNF and Betaseron® Tolerability Study (REFORMS)

Relapsing Remitting Multiple Sclerosis (RRMS)
NCT01024777

Completed

Safety and Immunologic Effect of Low Dose Versus High Dose Vitamin D3 in Multiple Sclerosis

Multiple Sclerosis | Vitamin D Deficiency
NCT01005095

Terminated

The Effects of Interferon Beta Combined With Vitamin D on Relapsing Remitting Multiple Sclerosis Patients

MULTIPLE SCLEROSIS
NCT00566579

Terminated

Cryotherapy for Human Papillomavirus Clearance in Biopsy-confirmed Cervical Low-grade Squamous Intraepithelial Lesions (Cryotherapy)

Human Papillomavirus Clearance at 12 Months
NCT00309101

Completed

An Open Study for Steroid Resistant, Non-Thymectomized MG Patients

Myasthenia Gravis
NCT00843258

Completed

Treatment for Mild Hip Dysplasia in Newborns

Developmental Dysplasia of the Hip
NCT00151294

Terminated

The Efficacy and Safety of Escitalopram for Depression in Multiple Sclerosis

Depression | Multiple Sclerosis
NCT07521982

Not yet recruiting

Comparison of Frailty, Physical Fitness Parameters, and Irisin Levels Between Patients With Multiple Sclerosis and Healthy Volunteers

MULTIPL SCLEROSİS
NCT07483450

Recruiting

A Study to Evaluate the Efficacy, Safety, Pharmacokinetics, and Pharmacodynamics of Ocrelizumab in Participants With Relapsing Multiple Sclerosis and Primary Progressive Multiple Sclerosis

Relapsing Multiple Sclerosis | Primary Progressive Multiple Sclerosis
NCT07079020

Not yet recruiting

Efgartigimod for Consolidation Therapy in gMG

Myasthenia Gravis

Clinical Trials on Borderline Resectable Adenocarcinoma of the Head of the Pancrease

Sponsors and Collaborators

Medical Conditions

Drug Interventions

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations